Scopus BioPharma is headquartered in New York, New York.
Scopus BioPharma disclosed revenue of 12M USD for 2022 and 28M USD for 2021.
Scopus BioPharma has 13 employees.
Scopus BioPharma is a life science company.
Scopus BioPharma was founded in 2017.
420 Lexington Avenue,
New York, New York
10170
United States,
(212) 479-2513
www.scopusbiopharma.com
Scopus BioPharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve its mission, the company seeks to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Scopus BioPharma was formed in 2017 and is based in New York City.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
